Rahul Kakkar
Chief Executive Officer at Pandion Operations, Inc.
Profile
Rahul joined Polaris Partners in 2021 and serves as an entrepreneur partner.
He is a biotech executive and physician-scientist, founding and building biotechnology companies as well as working as a practicing physician.
Most recently, Rahul was Chief Executive Officer at Pandion Therapeutics, a company focused on therapeutics for autoimmune and inflammatory diseases, which he led from Series A through its clinical transition, initial public offering and its ultimate acquisition by Merck for $1.85B.
Prior to joining Pandion, Rahul founded Corvidia Therapeutics, a precision cardiovascular company, where he served as Chief Medical Officer and Chief Strategy Officer.
Corvidia Therapeutics was acquired by Novo Nordisk for $2.1B.
Across his companies, Rahul has led fundraising totaling over $300M to date.
Prior to Corvidia, Rahul served as a director in the Emerging Innovations Unit at AstraZeneca, where he was recognized with the AstraZeneca Leadership Recognition Award.
Rahul continues to practice cardiovascular medicine at the Brigham and Women’s Hospital in Boston, and is a lecturer in medicine at Harvard Medical School.
Rahul received his B.A.
Cum Laude from Tufts University where he was a member of the Golden Key National Honor Society, and M.D.
from the Tufts University School of Medicine, where he was the recipient of the Louis Weinstein Prize in Clinical Medicine and was inducted into the Alpha Omega Alpha Honor Society as a junior.
He also served as an Albert Schweitzer Fellow.
Rahul Kakkar active positions
| Companies | Position | Start |
|---|---|---|
Pandion Operations, Inc.
 Pandion Operations, Inc. Miscellaneous Commercial ServicesCommercial Services Pandion Operations, Inc. develops drugs for autoimmune, inflammatory, and transplant indications. The company was founded by Anthony J. Coyle, Jo Viney, Alan Crane, and David Sachs in 2017 and is headquartered in Cambridge, MA. | Chief Executive Officer | 2019-07-16 |
Attralus, Inc.
 Attralus, Inc. Pharmaceuticals: MajorHealth Technology Attralus, Inc. operates as a biopharmaceutical company. The firm focuses on illuminating the systemic nature of amyloidosis and creating transformative medicines to improve the lives of patients. The company was founded by Jonathan Wall in 2019 and is headquartered in San Francisco, CA. | Director/Board Member | 2021-05-09 |
Tome Biosciences, Inc.
 Tome Biosciences, Inc. BiotechnologyHealth Technology Tome Biosciences, Inc. provides genomic medicine insertion and technologies services. The company is based in Cambridge, MA. The CEO of the company is Rahul Kakkar. | Chief Executive Officer | - |
Polaris Growth Management LLC
 Polaris Growth Management LLC Investment ManagersFinance Polaris Partners is an Independent Venture Capital firm founded in 1996 by Stephen D. Arnold, Jonathan A. Flint and Terrance G. McGuire. Polaris Partners is headquartered in Waltham. | Private Equity Investor | 2021-08-31 |
Former positions of Rahul Kakkar
| Companies | Position | End |
|---|---|---|
| PANDION THERAPEUTICS, INC. | Chief Executive Officer | 2021-03-31 |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Founder | 2019-04-30 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 2015-12-31 |
Training of Rahul Kakkar
| Tufts University | Undergraduate Degree |
| Tufts University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| Private companies | 6 |
|---|---|
Polaris Growth Management LLC
Polaris Growth Management LLC Investment ManagersFinance Polaris Partners is an Independent Venture Capital firm founded in 1996 by Stephen D. Arnold, Jonathan A. Flint and Terrance G. McGuire. Polaris Partners is headquartered in Waltham. | Finance |
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Health Technology |
Pandion Operations, Inc.
Pandion Operations, Inc. Miscellaneous Commercial ServicesCommercial Services Pandion Operations, Inc. develops drugs for autoimmune, inflammatory, and transplant indications. The company was founded by Anthony J. Coyle, Jo Viney, Alan Crane, and David Sachs in 2017 and is headquartered in Cambridge, MA. | Commercial Services |
Pandion Therapeutics, Inc.
 Pandion Therapeutics, Inc. BiotechnologyHealth Technology Pandion Therapeutics, Inc. is a clinical stage biopharmaceutical company. It develops Therapeutic Autoimmune reguLatOry proteiN (TALON) drug design and discovery platform, which employ a modular approach to create a pipeline of product candidates using immunomodulatory effector modules that act at known control nodes within the immune network. The company was founded by Dr. Joanne Viney on September 19, 2016 and is headquartered in Watertown, MA. | Health Technology |
Attralus, Inc.
Attralus, Inc. Pharmaceuticals: MajorHealth Technology Attralus, Inc. operates as a biopharmaceutical company. The firm focuses on illuminating the systemic nature of amyloidosis and creating transformative medicines to improve the lives of patients. The company was founded by Jonathan Wall in 2019 and is headquartered in San Francisco, CA. | Health Technology |
Tome Biosciences, Inc.
Tome Biosciences, Inc. BiotechnologyHealth Technology Tome Biosciences, Inc. provides genomic medicine insertion and technologies services. The company is based in Cambridge, MA. The CEO of the company is Rahul Kakkar. | Health Technology |
- Stock Market
- Insiders
- Rahul Kakkar
